AZD 6244

cyclin dependent kinase 2 ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35523987 Discovery of novel targets and mechanisms of MEK inhibitor Selumetinib for LGG treatment based on molecular docking and molecular dynamics simulation. 2022 May 6 2
2 22641227 Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma. 2012 Aug 1